Fosun Pharma Announces 2025 Annual Results (opens in new tab)

&#8230; <span class="match">business</span> R&amp;D <span class="match">investment</span>. High-intensity R&amp;D <span class="match">investment</span> &#8230; List (NRDL), and the <span class="match">CAR</span>-T therapy &#8230; and neurodegenerative diseases, the <span class="match">Company</span> continuously strengthens its &#8230; <span class="match">market</span>, covering China, Europe, <span class="match">Latin America</span>, Southeast Asia, India and other <span class="matc...